RIANA Therapeutics enters into collaboration agreement with LDC

"This cooperation has the great potential to lay the groundwork for new, urgently needed therapeutic approaches for AML patients"

13-Sep-2023 - RIANA Therapeutics, a spin-off from Vetmeduni Vienna has entered into a collaborative agreement with the Lead Discovery Center GmbH, a renowned organization specialized in translational drug discovery. This partnership marks the first important milestone on RIANA Therapeutics´ mission to discover ...

RIANA Therapeutics signs license agreement with Vetmeduni and expands team

21-Jun-2023 - In spring 2023, RIANA Therapeutics, a spin-off of Vetmeduni, kicked off its operations. With the aim of developing innovative cancer therapeutics, this biotech start-up leverages groundbreaking scientific insights from Vetmeduni's Unit of Functional Cancer Genomics. A significant milestone has ...

"Dr Jekyll and Mr Hyde" technique to fight cancer

Viennese start-up develops novel, precise anti-cancer drugs

06-Mar-2023 - RIANA Therapeutics, a promising pharmaceutical start-up recently spun out of the University of Veterinary Medicine Vienna (Vetmeduni), aims to develop novel therapeutics for cancer patients based in part on scientific findings from Vetmeduni’s Moriggl research group (Moriggl Lab). The ...